BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36549593)

  • 1. Clustered variants in the 5' coding region of TRA2B cause a distinctive neurodevelopmental syndrome.
    Ramond F; Dalgliesh C; Grimmel M; Wechsberg O; Vetro A; Guerrini R; FitzPatrick D; Poole RL; Lebrun M; Bayat A; Grasshoff U; Bertrand M; Witt D; Turnpenny PD; Faundes V; Santa María L; Mendoza Fuentes C; Mabe P; Hussain SA; Mullegama SV; Torti E; Oehl-Jaschkowitz B; Salmon LB; Orenstein N; Shahar NR; Hagari O; Bazak L; Hoffjan S; Prada CE; Haack T; Elliott DJ
    Genet Med; 2023 Apr; 25(4):100003. PubMed ID: 36549593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress-induced alternative splicing of transformer 2beta (SFRS10) and CD44 pre-mRNAs in gastric epithelial cells.
    Takeo K; Kawai T; Nishida K; Masuda K; Teshima-Kondo S; Tanahashi T; Rokutan K
    Am J Physiol Cell Physiol; 2009 Aug; 297(2):C330-8. PubMed ID: 19439532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HnRNPA1 interacts with G-quadruplex in the TRA2B promoter and stimulates its transcription in human colon cancer cells.
    Nishikawa T; Kuwano Y; Takahara Y; Nishida K; Rokutan K
    Sci Rep; 2019 Jul; 9(1):10276. PubMed ID: 31311954
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Shatokhina O; Kovalskaia V; Sparber P; Sharkova I; Mishina I; Kuznetsova V; Ryzhkova O
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HuR regulates alternative splicing of the TRA2β gene in human colon cancer cells under oxidative stress.
    Akaike Y; Masuda K; Kuwano Y; Nishida K; Kajita K; Kurokawa K; Satake Y; Shoda K; Imoto I; Rokutan K
    Mol Cell Biol; 2014 Aug; 34(15):2857-73. PubMed ID: 24865968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons.
    Best A; James K; Dalgliesh C; Hong E; Kheirolahi-Kouhestani M; Curk T; Xu Y; Danilenko M; Hussain R; Keavney B; Wipat A; Klinck R; Cowell IG; Cheong Lee K; Austin CA; Venables JP; Chabot B; Santibanez Koref M; Tyson-Capper A; Elliott DJ
    Nat Commun; 2014 Sep; 5():4760. PubMed ID: 25208576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down the expression of TRA2β inhibits the proliferation and migration of human glioma cells.
    Yang L; Tao T; Wang Y; Bao Z; He X; Cui G
    Pathol Res Pract; 2015 Oct; 211(10):731-9. PubMed ID: 26298634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of evolutionarily conserved exons as regulated targets for the splicing activator tra2β in development.
    Grellscheid S; Dalgliesh C; Storbeck M; Best A; Liu Y; Jakubik M; Mende Y; Ehrmann I; Curk T; Rossbach K; Bourgeois CF; Stévenin J; Grellscheid D; Jackson MS; Wirth B; Elliott DJ
    PLoS Genet; 2011 Dec; 7(12):e1002390. PubMed ID: 22194695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De Novo Frameshift Variants in the Neuronal Splicing Factor NOVA2 Result in a Common C-Terminal Extension and Cause a Severe Form of Neurodevelopmental Disorder.
    Mattioli F; Hayot G; Drouot N; Isidor B; Courraud J; Hinckelmann MV; Mau-Them FT; Sellier C; Goldman A; Telegrafi A; Boughton A; Gamble C; Moutton S; Quartier A; Jean N; Van Ness P; Grotto S; Nambot S; Douglas G; Si YC; Chelly J; Shad Z; Kaplan E; Dineen R; Golzio C; Charlet-Berguerand N; Mandel JL; Piton A
    Am J Hum Genet; 2020 Apr; 106(4):438-452. PubMed ID: 32197073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How does Tra2β protein regulate tissue-specific RNA splicing?
    Elliott DJ; Best A; Dalgliesh C; Ehrmann I; Grellscheid S
    Biochem Soc Trans; 2012 Aug; 40(4):784-8. PubMed ID: 22817734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.
    Kuwano Y; Nishida K; Kajita K; Satake Y; Akaike Y; Fujita K; Kano S; Masuda K; Rokutan K
    Cell Death Differ; 2015 May; 22(5):815-25. PubMed ID: 25342468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Tra2beta isoforms is developmentally regulated in a tissue- and temporal-specific pattern.
    Chen X; Guo L; Lin W; Xu P
    Cell Biol Int; 2003; 27(6):491-6. PubMed ID: 12798777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets1 and heat shock factor 1 regulate transcription of the Transformer 2β gene in human colon cancer cells.
    Kajita K; Kuwano Y; Kitamura N; Satake Y; Nishida K; Kurokawa K; Akaike Y; Honda M; Masuda K; Rokutan K
    J Gastroenterol; 2013 Nov; 48(11):1222-33. PubMed ID: 23361474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variants in SCAF4 Cause a Neurodevelopmental Disorder and Are Associated with Impaired mRNA Processing.
    Fliedner A; Kirchner P; Wiesener A; van de Beek I; Waisfisz Q; van Haelst M; Scott DA; Lalani SR; Rosenfeld JA; Azamian MS; Xia F; Dutra-Clarke M; Martinez-Agosto JA; Lee H; ; Noh GJ; Lippa N; Alkelai A; Aggarwal V; Agre KE; Gavrilova R; Mirzaa GM; Straussberg R; Cohen R; Horist B; Krishnamurthy V; McWalter K; Juusola J; Davis-Keppen L; Ohden L; van Slegtenhorst M; de Man SA; Ekici AB; Gregor A; van de Laar I; Zweier C
    Am J Hum Genet; 2020 Sep; 107(3):544-554. PubMed ID: 32730804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Splicing factor transformer-2β (Tra2β) regulates the expression of regulator of G protein signaling 4 (RGS4) gene and is induced by morphine.
    Li SJ; Li Y; Cui SC; Qi Y; Zhao JJ; Liu XY; Xu P; Chen XH
    PLoS One; 2013; 8(8):e72220. PubMed ID: 23977258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular design of a splicing switch responsive to the RNA binding protein Tra2β.
    Grellscheid SN; Dalgliesh C; Rozanska A; Grellscheid D; Bourgeois CF; Stévenin J; Elliott DJ
    Nucleic Acids Res; 2011 Oct; 39(18):8092-104. PubMed ID: 21724598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tra2beta as a novel mediator of vascular smooth muscle diversification.
    Shukla S; Fisher SA
    Circ Res; 2008 Aug; 103(5):485-92. PubMed ID: 18669920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANK3 related neurodevelopmental disorders: expanding the spectrum of heterozygous loss-of-function variants.
    Kloth K; Lozic B; Tagoe J; Hoffer MJV; Van der Ven A; Thiele H; Altmüller J; Kubisch C; Au PYB; Denecke J; Bijlsma EK; Lessel D
    Neurogenetics; 2021 Oct; 22(4):263-269. PubMed ID: 34218362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine/serine-rich protein interaction domain-dependent modulation of a tau exon 10 splicing enhancer: altered interactions and mechanisms for functionally antagonistic FTDP-17 mutations Delta280K AND N279K.
    D'Souza I; Schellenberg GD
    J Biol Chem; 2006 Feb; 281(5):2460-9. PubMed ID: 16308321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De novo MCM6 variants in neurodevelopmental disorders: a recognizable phenotype related to zinc binding residues.
    Smits DJ; Schot R; Popescu CA; Dias KR; Ades L; Briere LC; Sweetser DA; Kushima I; Aleksic B; Khan S; Karageorgou V; Ordonez N; Sleutels FJGT; van der Kaay DCM; Van Mol C; Van Esch H; Bertoli-Avella AM; Roscioli T; Mancini GMS
    Hum Genet; 2023 Jul; 142(7):949-964. PubMed ID: 37198333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.